Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


Contact Us


1444 Eye Street, NW, Ste. 910
Washington, DC 20005-6573

Sen. Roy Blunt
Honorary Co-Chairman

Sen. Ben Cardin
Honorary Co-Chairman

Dr. Bob Graham

Upcoming Briefings

Wednesday, October 26, 2016: Medicare and Prescription Drug Prices

While recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, and preventing disease, stakeholders throughout the health care system have serious concerns about prescription drug affordability. Payment methods that incorporate concepts of value and patient-centered care are among the emerging policy options to address the cost of drugs for Medicare patients. This briefing will feature short presentations by our experts highlighting the trends in Medicare regarding prescription drug pricing, and panelists will discuss an array of policy options to align drug prices with value through alternative payment models.   Info & Registration 

Recent Briefings

The enactment of the Veterans Choice Act in 2014 renewed discussions about the capacity of the VA health care system to meet the needs of our nation's veterans. In addition to tackling issues related to access to VA-owned facilities, the Veterans Choice Act prompted a thorough examination of the quality of care provided to veterans in the VA system, the VA's ability to purchase care from the private sector, and the VA's capacity to provide services. This briefing provided an introduction to the VA health system, presented an overview of how the VA acts as both provider and purchaser of care, and discussed policy prospects for the future. Read More

The Affordable Care Act's health insurance marketplaces rely on robust competition to control costs and to provide consumer choice. But the decisions of several large insurers to scale back their 2017 marketplace participation, and the failure of many health insurance co-ops will leave marketplace shoppers in many states with fewer choices than they had in 2016. Furthermore, those insurers remaining in the exchanges have often found their marketplace customers to be less healthy than they projected, and they are raising premiums in response. Our briefing focuses on these trends, what they mean for the long-term viability of the marketplaces, and what public policy steps can be taken to bring more healthy people into the risk pool and to encourage insurer participation in the individual market. Read More

Medicaid is testing numerous new alternative payment and delivery system models to enhance the coordination of the health care services provided to millions of low-income Americans. This briefing examined the range of Medicaid’s efforts to improve care and promote value, including integrating health with non-clinical and behavioral services, creating managed care organizations, and instituting regional care collaborative organizations. Read More

Health systems have applied many innovative new strategies for improving quality and reducing costs when it comes to care for high-need, high-cost patients, who typically have multiple chronic conditions. Which of these innovations show promise, and what can we learn from them? This briefing defines who high-need, high-cost patients are, discusses the importance of this population to health system transformation, presents current data on this population, and emphasizes the core elements of successful interventions.  Read More

Assessing Innovations in Medicaid

Get Alliance Updates

Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds

Webcast: The Emerging Biosimilars Market

Watch the webcast of our June 20 panel discussion on biosimilar biological medications.

Read More

Copyright 1997-2016 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      Sitemap